Description
xPromensil Original Naturally occurring red clover isoflavones for women during and after the menopause.Highly recommended throughout the menopause as a maintenance dose. Promensil Original is specifically formulated to provide a maintenance dose of active ingredient for optimum support throughout menopause. Key facts:⢠Maintenance dose (40mg of red clover isoflavones)⢠Use throughout menopause⢠Contains 4 isoflavones⢠High bioavailability⢠No added sugar, yeast, milk derivatives, wheat and corn starch, gluten or artificial flavours⢠Suitable for Vegans and VegetariansFeatures & Benefits:For women who look for alternative solutions for menopause. Promensil is a dietary supplement based on red clover isoflavones specifically developed to provide support and wellbeing for women during and after the menopause. Promensilâs red clover isoflavones are naturally occurring plant oestrogens that have been specifically extracted and are not chemically synthesised.Promensil is the most extensively studied menopause supplement. Promensil has been used in international scientific research into effects of red clover supplementation during menopause for over 15 years. Promensil has a good safety profile and studies have shown that Promensil may help to promote general wellbeing during and after the menopause.Â
Product informationPromensil Original
Naturally occurring red clover isoflavones for women during and after the menopause.
Highly recommended throughout the menopause as a maintenance dose. Promensil Original is specifically formulated to provide a maintenance dose of active ingredient for optimum support throughout menopause.
Key facts:
Maintenance dose (40mg of red clover isoflavones)
Use throughout menopause
Contains 4 isoflavones
High bioavailability
No added sugar, yeast, milk derivatives, wheat and corn starch, gluten or artificial flavours
Suitable for Vegans and Vegetarians
Features & Benefits:
For women who look for alternative solutions for menopause. Promensil is a dietary supplement based on red clover isoflavones specifically developed to provide support and wellbeing for women during and after the menopause. Promensils red clover isoflavones are naturally occurring plant oestrogens that have been specifically extracted and are not chemically synthesised.
Promensil is the most extensively studied menopause supplement. Promensil has been used in international scientific research into effects of red clover supplementation during menopause for over 15 years. Promensil has a good safety profile and studies have shown that Promensil may help to promote general wellbeing during and after the menopause.
Preparation and Usage
Dosage:
As a supplement, take one or two tablets daily with your main meal, or as directed by your healthcare professional. Initially we recommend a minimum of 4-12 weeks intake.
Cautions:
Do not exceed the recommended dosage. Food supplements should not replace a balanced diet and healthy lifestyle. If you are under medical supervision, please consult your healthcare professional before use. Not for use by pregnant or lactating women. Keep out of sight and reach of children. Store below 25C in a dry place, out of direct sunlight.
Brand
Promensil
Ingredients
Bulking agents (Dicalcium Phosphate, Microcrystalline Cellulose), Red Clover Extract (Trifolium pratense), Tablet Coating (Hydroxypropylmethyl Cellulose, Colours: Titanium Dioxide & Iron Oxides, Polyethylene Glycol), Anti-caking agents (Silicon Dioxide, Magnesium Stearate), Alpha Tocopherol (Antioxidant), Cross-linked sodium carboxymethyl cellulose (Emulsifier).
Shipping Details
xWe deliver to over 120 countries || Whilst certain products cannot be delivered outside UK, some products may be subject customs and excise duties || We confirm if this product can be delivered to your location (outside the UK) when you enter your delivery address at checkout. If you are unable to checkout, please contact us via WhatsApp or email hello@mcgrocer.com to enquire if this product can be delivered to your location and to process your order via our live chat.
